We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2009 by Glostrup University Hospital, Copenhagen.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00770406
First Posted: October 10, 2008
Last Update Posted: August 4, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Glostrup University Hospital, Copenhagen
October 9, 2008
October 10, 2008
August 4, 2009
January 2009
June 2010   (Final data collection date for primary outcome measure)
Incontinence episode frequency [ Time Frame: 1 year ]
Same as current
Complete list of historical versions of study NCT00770406 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence
Intravesikal Instillation af Botulinum Toxin Type A Til Patienter Med Urge Urininkontinens
A pilot study to examine efficacy and safety of intravesical botulinum toxin type A.
Not Provided
Interventional
Phase 1
Phase 2
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Urge Urinary Incontinence
Drug: botulinum toxin type A
100 or 200 units intravesically
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
20
June 2010
June 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • refractory urge urinary incontinence

Exclusion Criteria:

  • neurological disease
  • pregnant or lactating
  • bladder neoplasias
Sexes Eligible for Study: Female
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
 
NCT00770406
BTXA2008
No
Not Provided
Not Provided
Soren Brostrom, MD, PhD, Glostrup University Hospital,Copenhagen
Glostrup University Hospital, Copenhagen
Not Provided
Not Provided
Glostrup University Hospital, Copenhagen
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP